카사바 (SAVA)

Dec 05, 2025

Why Cassava Sciences Inc. Equity Warrant stock is rated strong buyDividend Hike & High Accuracy Investment Signals - Newser

Dec 05, 2025

Dec 05, 2025

Why Cassava Sciences Inc. (PX91) stock appeals to dividend investors2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - Newser

Dec 05, 2025

Dec 05, 2025

Why Cassava Sciences Inc. (PX91) stock could be next leader2025 Market Trends & Weekly Consistent Profit Watchlists - Newser

Dec 05, 2025

Dec 04, 2025

Can Cassava Sciences Inc. (PX91) stock deliver double digit returnsJuly 2025 Opening Moves & Reliable Price Action Trade Plans - Newser

Dec 04, 2025

Dec 04, 2025

What analysts say about Cassava Sciences Inc Equity Warrant stock - earlytimes.in

Dec 04, 2025

Dec 04, 2025

How Cassava Sciences Inc. Equity Warrant stock compares to industry benchmarksPortfolio Value Summary & AI Forecasted Entry and Exit Points - Newser

Dec 04, 2025

Dec 04, 2025

How Cassava Sciences Inc. (PX91) stock trades after rate cuts2025 Performance Recap & AI Powered Buy/Sell Recommendations - Newser

Dec 04, 2025

Dec 03, 2025

Cassava Sciences IncFDA requires additional information from Cassava for clinical studySEC filing - marketscreener.com

Dec 03, 2025

Dec 03, 2025

Cassava Says US FDA Seeks Additional Information for Simufilam IND Application for TSC-Related Epilepsy - MarketScreener

Dec 03, 2025

Dec 03, 2025

Cassava Sciences hit with FDA request for more data on simufilam trial (SAVA:NASDAQ) - Seeking Alpha

Dec 03, 2025

Dec 03, 2025

Cassava Sciences receives FDA request for more information on epilepsy trial - Investing.com

Dec 03, 2025

Dec 03, 2025

Cassava Sciences Submits IND Application for Simufilam - TipRanks

Dec 03, 2025

Dec 03, 2025

Cassava Sciences stock falls after FDA requests more data for epilepsy drug - Investing.com Canada

Dec 03, 2025

Dec 03, 2025

Does Cassava Sciences Inc. stock trade at a discount to peersAnalyst Downgrade & Weekly High Return Stock Forecasts - Newser

Dec 03, 2025

Dec 03, 2025

Cassava Sciences Receives FDA Request for Additional Information - TradingView

Dec 03, 2025

Dec 03, 2025

Will Cassava Sciences Inc. (PX91) stock beat Nasdaq index returnsJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser

Dec 03, 2025

Dec 02, 2025

Is Cassava Sciences Inc. stock a buy for dividend growthJuly 2025 Market Mood & Low Risk Investment Opportunities - Newser

Dec 02, 2025

Dec 02, 2025

Published on: 2025-12-02 02:52:36 - Newser

Dec 02, 2025

Nov 27, 2025

How Cassava Sciences Inc. stock responds to policy changesJuly 2025 Patterns & Growth Oriented Trade Recommendations - BỘ NỘI VỤ

Nov 27, 2025

Nov 27, 2025

Can Cassava Sciences Inc. stock outperform in 2025 bull marketWeekly Trade Report & Free Weekly Watchlist of Top Performers - moha.gov.vn

Nov 27, 2025

Nov 26, 2025

Aug Sectors: What valuation multiples suggest for Cassava Sciences Inc. Equity Warrant stockDollar Strength & Real-Time Sentiment Analysis - BỘ NỘI VỤ

Nov 26, 2025

Nov 25, 2025

Dir Anderson Jr Buys 8,600 ($24.9K) Of Cassava Sciences Inc [SAVA] - TradingView

Nov 25, 2025

Nov 25, 2025

[Form 4] CASSAVA SCIENCES INC Insider Trading Activity - Stock Titan

Nov 25, 2025

Nov 24, 2025

Cassava Sciences rises 10% after market close on CEO stock buy - MSN

Nov 24, 2025

Nov 23, 2025

February 10, 2025 Deadline: Contact Levi & Korsinsky to Join Cla - GuruFocus

Nov 23, 2025

Nov 22, 2025

Down -39.52% in 4 Weeks, Here's Why Cassava Sciences (SAVA) Looks Ripe for a Turnaround - MSN

Nov 22, 2025

Nov 21, 2025

Cassava Sciences (NASDAQ:SAVA) CEO Purchases $201,808.75 in Stock - MarketBeat

Nov 21, 2025

Nov 21, 2025

Should You Invest in Dishman Carbogen Amcis Limited Before Its Next Earnings ReportEvening Star Patterns & Rapid Capital Portfolio - earlytimes.in

Nov 21, 2025

Nov 21, 2025

Cassava Sciences Sees Unusually High Options Volume (NASDAQ:SAVA) - MarketBeat

Nov 21, 2025

Nov 21, 2025

Cassava Sciences Stock Rise as CEO Makes Insider Purchase - Somos Hermanos -

Nov 21, 2025

Nov 21, 2025

Is Cassava Sciences Inc. stock attractive for retirement portfoliosGap Up & Safe Capital Allocation Plans - newser.com

Nov 21, 2025

Nov 21, 2025

Cassava Sciences stock up as CEO buys shares (SAVA:NASDAQ) - Seeking Alpha

Nov 21, 2025

Nov 21, 2025

Is Cassava Sciences Inc. stock attractive for income investorsMarket Trend Report & AI Enhanced Trading Signals - newser.com

Nov 21, 2025

Nov 20, 2025

Is Cassava Sciences Inc. stock a defensive play in 2025Market Performance Report & AI Powered Market Entry Strategies - newser.com

Nov 20, 2025

Nov 20, 2025

Why global investors buy Cassava Sciences Inc. (PX91) stockPortfolio Value Summary & Low Risk High Reward Trade Ideas - newser.com

Nov 20, 2025

Nov 20, 2025

Why Cassava Sciences Inc. Equity Warrant stock could be next big winnerPortfolio Profit Report & Real-Time Volume Trigger Notifications - newser.com

Nov 20, 2025

Nov 20, 2025

Can Cassava Sciences Inc. stock deliver consistent earnings growth2025 Volatility Report & Fast Entry High Yield Tips - newser.com

Nov 20, 2025

Nov 19, 2025

Why Cassava Sciences Inc. Equity Warrant stock is favored by top institutions2025 Key Highlights & Capital Protection Trading Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

What momentum indicators show for Cassava Sciences Inc. stockGold Moves & Real-Time Chart Breakout Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Will Cassava Sciences Inc. Equity Warrant stock deliver shareholder value - newser.com

Nov 19, 2025